P. Franken

发表

The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.

S. Arold, P. Franken, M. Strub, 1997, Structure.

HIV‐1 Nef protein: Purification, crystallizations, and preliminary X‐ray diffraction studies

S. Arold, P. Franken, M. Strub, 1997, Protein science : a publication of the Protein Society.

The importance of glycine-30 for enzymatic activity of phospholipase A2.

P. Franken, H. Verheij, G. de Haas, 1991, Biochimica et biophysica acta.

Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2.

L. Touqui, B. Vargaftig, P. Franken, 1994, Biochimica et biophysica acta.

The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.

P. Franken, C. Mounier, C. Bon, 1996, European journal of biochemistry.

Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.

P. Franken, H. Verheij, G. de Haas, 1992, European journal of biochemistry.

RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.

S. Arold, P. Franken, M. Strub, 1998, Biochemistry.

The use of genetic engineering to obtain efficient production of porcine pancreatic phospholipase A2 by Saccharomyces cerevisiae.

P. Franken, H. Verheij, G. de Haas, 1991, Biochimica et biophysica acta.

An extended binding pocket determines the polar head group specificity of porcine pancreatic phospholipase A2.

P. Franken, S. Beiboer, H. Verheij, 1995, European journal of biochemistry.

Crystal structure of a porcine pancreatic phospholipase A2 mutant. A large conformational change caused by the F63V point mutation.

K. H. Kalk, J. Drenth, B. Dijkstra, 1993, Journal of molecular biology.

Competitive inhibition of lipolytic enzymes. VI. Inhibition of two human phospholipases A2 by acylamino phospholipid analogues.

P. Franken, H. Verheij, G. de Haas, 1992, Biochimica et biophysica acta.

Site-directed mutagenesis and X-ray crystallography of two phospholipase A2 mutants: Y52F and Y73F.

K. H. Kalk, J. Drenth, B. Dijkstra, 1992, Protein engineering.